These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35927161)

  • 1. Impact of a pharmacist-led outpatient telemedicine clinic on chronic obstructive pulmonary disease in a veteran population.
    Howard O; Thomas A; Henry H; Wallace J
    J Am Pharm Assoc (2003); 2022; 62(6):1919-1924. PubMed ID: 35927161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized trial of pragmatic education for low-risk COPD patients: impact on hospitalizations and emergency department visits.
    Siddique HH; Olson RH; Parenti CM; Rector TS; Caldwell M; Dewan NA; Rice KL
    Int J Chron Obstruct Pulmon Dis; 2012; 7():719-28. PubMed ID: 23118535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacists' chronic disease management in chronic obstructive pulmonary disease: Effect on health services utilization.
    Makhinova T; Johnson JA; Minhas-Sandhu JK; Necyk C; Bhutani M; Eurich DT
    J Manag Care Spec Pharm; 2023 Jun; 29(6):671-679. PubMed ID: 37276041
    [No Abstract]   [Full Text] [Related]  

  • 5. Implementation of an emergency department-based clinical pharmacist transitions-of-care program.
    Hohner E; Ortmann M; Murtaza U; Chopra S; Ross PA; Swarthout M; Efird L; Pherson E; Saheed M
    Am J Health Syst Pharm; 2016 Aug; 73(15):1180-7. PubMed ID: 27440625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of a pharmacist-led spirometry clinic.
    Rutschilling R; Schrader J; Draime JA; Straw A; Barhorst R
    J Am Pharm Assoc (2003); 2023; 63(4S):S101-S105. PubMed ID: 36609055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Impact of a Pharmacist-Led Telehealth Clinic on Diabetes-Related Goals of Therapy in a Veteran Population.
    Maxwell LG; McFarland MS; Baker JW; Cassidy RF
    Pharmacotherapy; 2016 Mar; 36(3):348-56. PubMed ID: 26877253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
    Blais L; Forget A; Ramachandran S
    Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of clinical pharmacist services delivered via telemedicine in the outpatient or ambulatory care setting: A systematic review.
    Niznik JD; He H; Kane-Gill SL
    Res Social Adm Pharm; 2018 Aug; 14(8):707-717. PubMed ID: 29100941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoting Community Pharmacy Practice for Chronic Obstructive Pulmonary Disease (COPD) Management: A Systematic Review and Logic Model.
    Hu Y; Yao D; Ung COL; Hu H
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1863-1875. PubMed ID: 32821091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of patient-specific inhaler regimens with the use of the aerosol inhalation monitor.
    Blum E; Thavarajah K; Martirosov AL
    J Am Pharm Assoc (2003); 2019; 59(2):252-257. PubMed ID: 30552051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishing a pharmacist-managed outreach clinic at a day shelter for homeless veterans.
    Haake ER; Krieger KJ
    Ment Health Clin; 2020 Jul; 10(4):232-236. PubMed ID: 32685334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A home telemonitoring program reduced exacerbation and healthcare utilization rates in COPD patients with frequent exacerbations.
    Alrajab S; Smith TR; Owens M; Areno JP; Caldito G
    Telemed J E Health; 2012 Dec; 18(10):772-6. PubMed ID: 23082792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Chronic Disease Home Telehealth Monitoring in the Veterans Health Administration on Healthcare Utilization and Mortality.
    Mohr NM; Vakkalanka JP; Holcombe A; Carter KD; McCoy KD; Clark HM; Gutierrez J; Merchant KAS; Bailey GJ; Ward MM
    J Gen Intern Med; 2023 Nov; 38(15):3313-3320. PubMed ID: 37157039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthcare Utilization in Patients with Chronic Obstructive Pulmonary Disease Discharged from Coronavirus 2019 Hospitalization.
    Puebla Neira D; Zaidan M; Nishi S; Duarte A; Lau C; Parthasarathy S; Wang J; Kuo YF; Sharma G
    Int J Chron Obstruct Pulmon Dis; 2023; 18():1827-1835. PubMed ID: 37636902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease management program for chronic obstructive pulmonary disease: a randomized controlled trial.
    Rice KL; Dewan N; Bloomfield HE; Grill J; Schult TM; Nelson DB; Kumari S; Thomas M; Geist LJ; Beaner C; Caldwell M; Niewoehner DE
    Am J Respir Crit Care Med; 2010 Oct; 182(7):890-6. PubMed ID: 20075385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COPD Management in Community Pharmacy Results in Improved Inhaler Use, Immunization Rate, COPD Action Plan Ownership, COPD Knowledge, and Reductions in Exacerbation Rates.
    Fathima M; Bawa Z; Mitchell B; Foster J; Armour C; Saini B
    Int J Chron Obstruct Pulmon Dis; 2021; 16():519-533. PubMed ID: 33688177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of a pharmacist-led substance use disorder transitions of care clinic on postdischarge medication treatment retention.
    Smith A; Hansen J; Colvard M
    J Subst Abuse Treat; 2021 Nov; 130():108440. PubMed ID: 34118708
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.